Patients in both the radiotherapy and non-radiotherapy groups were predominantly 40-60 years old, white, married, histological type of ductal carcinoma, had grade II and III tumors, no distant metastasis, breast cancer subtype of HR+/HER2-, and underwent implant reconstruction. Here, ERBB2 is linked to breast ductal adenocarcinoma.